ArticleClinical pharmacokinetics2018

Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Hepatitis C Virus-Infected Cirrhotic and Non-cirrhotic Patients: Analyses Across Nine Phase III Studies.

Sathej Gopalakrishnan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.